2,865
Views
13
CrossRef citations to date
0
Altmetric
Research Article

mPEG-icariin nanoparticles for treating myocardial ischaemia

, , , , , , , , & show all
Pages 799-809 | Received 30 Sep 2018, Accepted 23 Oct 2018, Published online: 06 Mar 2019

References

  • Laslett LJ, Alagona P, Clark BA, et al. The worldwide environment of cardiovascular disease: prevalence, diagnosis, therapy, and policy issues: A report from the american college of cardiology. J Am Coll Cardiol. 2012;60:S1–S49.
  • Huang H, Yao QY, Xia EH, et al. Metabolomics and transcriptomics analyses reveal nitrogen influences on the accumulation of flavonoids and amino acids in young shoots of tea plant (Camellia sinensis L.) associated with tea flavor. J Agric Food Chem 2018;17:158–170.
  • Zhang WD, Chen H, Zhang C, et al. Astragaloside IV from Astragalus membranaceus shows cardioprotection during myocardial ischemia in vivo and in vitro. Planta Med. 2006;72:4–8.
  • Liu HJ, Liu XY, Jing DB. Icariin induces the growth, migration and osteoblastic differentiation of human periodontal ligament fibroblasts by inhibiting Toll-like receptor 4 and NF-κB p65 phosphorylation. Mol Med Rep. 2018;18:3325–3331.
  • Liu SY, Wu HJ. Research progress of icariin pharmacologic action. Med Recapit 2009;6:909–912.
  • Wang Z, Wang D, Yang D, et al. The effect of icariin on bone metabolism and its potential clinical application. Osteoporos Int. 2018; 29:535–544.
  • Zhang Y, Sai LI, Ding XS. Effect of icariin on the vasodilation function of renal artery in diabetic nephropathy rats. Pharm Clin Res. 2016;3:209–211.
  • Zhang L, Zhang X, Li KF, et al. Icariin promotes extracellular matrix synthesis and gene expression of chondrocytes in vitro. Phytother Res. 2012;26:1385–1392.
  • Xu S, Yu J, Zhan J, et al. Pharmacokinetics, tissue distribution, and metabolism study of icariin in rat. Biomed Res Int. 2017;9:4684–4702.
  • Jia LL, Yuan D, Wang HW, et al. The pharmacological research advance of icariin. Prog Mod Biomed. 2010;20:3976–3979.
  • Gao M, Ma FF, Wu SH, et al. Research advance in the pharmacological effects of icariin. Med Plant. 2013;1:79–82.
  • Yan H, Zhou Z, Huang T, et al. Controlled release in vitro of icariin from gelatin/hyaluronic acid composite microspheres. Polym Bull. 2016;73:1055–1066.
  • Pan P, Chen J, Fan T, et al. Facile preparation of biphasic-induced magnetic icariin-loaded composite microcapsules by automated in situ click technology. Colloids Surf B Biointerfaces. 2016;140:50–59.
  • Li C, Li Q, Mei Q, et al. Pharmacology effects and pharmacokinetics properties of icariin, the major bioactive component in herba epimedii. Life Sci. 2015;126:57–68.
  • Liu X, Li H, Chen Y, et al. Mixed‐charge nanoparticles for long circulation, low reticuloendothelial system clearance, and high tumor accumulation. Adv Healthcare Mater. 2014;3:1439–1447.
  • Heaslet H, Harris M, Fahnoe K, et al. Structural comparison of chromosomal and exogenous dihydrofolate reductase from Staphylococcus aureus in complex with the potent inhibitor trimethoprim. Proteins. 2010;76:706–717.
  • Shao CY, Tu JS. Design strategy of antitumor polymer micelles. Pharm Clin Res. 2010;18:286–290.
  • Gubernator J. Active methods of drug loading into liposomes: recent strategies for stable drug entrapment and increased in vivo activity. Expert Opin Drug Deliv. 2011;8:565–580.
  • Kozlowski A, Charles SA, Harris JM. Development of PEGylated interferons for the treatment of chronic hepatitis c. Biodrugs. 2001;15:419–429.
  • Wang R, Xu Y. Development and evaluation of nanoparticles based on mPEG-PLA for controlled delivery of vinpocetine: in vitro and in vivo studies. Artif Cells Nanomed Biotechnol. 2017; 45:157–162.
  • George S, Parameswaran MK, Chakraborty AR, et al. Synthesis and evaluation of the biological activities of some 3-{[5-(6-methyl-4-aryl-2-oxo-1,2,3,4-tetrahydropyrimidin-5-yl)-1,3,4-oxadiazol-2-yl]-imino}-1,3-dihydro-2h-indol-2-one derivatives. Acta Pharm 2008;58:119–129.
  • Yao CX, Shi XL, Xiao L, et al. Increased cardiac distribution of mono-PEGylated radix ophiopogonis polysaccharide in both myocardial infarction and ischemia/reperfusion rats. Int J Nanomed 2015;10:409–418.
  • Eicher T, Hauptmann S, Speicher A. The chemistry of heterocycles: structure, reactions, syntheses, and application. 2nd ed. Weinheim, Germany: Wiley-VCH; 2003; p. 310–380.
  • Wang J, Sui M, Fan W. Nanoparticles for tumor targeted therapies and their pharmacokinetics. Curr Drug Metab 2010;11:129–141.
  • Maitra A. Calcium phosphate nanoparticles: second-generation nonviral vectors in gene therapy. Expert Rev Mol Diagn. 2005;5:893–905.
  • Zhang H, Zhang C, Ping Q. Research and application of polymeric micelles as drug carriers. Prog Pharm Sci 2002;6:326–329.
  • Barua S, Mitragotri S. Challenges associated with penetration of nanoparticles across cell and tissue barriers: a review of current status and future prospects. Nano Today. 2014;9:223–243.
  • Maeda H. Tumor-selective delivery of macromolecular drugs via the epr effect: background and future prospects. Bioconjugate Chem. 2010;21:797–802.
  • Yuan Y, Xu S, Zhang CJ, et al. Light-responsive AIE nanoparticles with cytosolic drug release to overcome drug resistance in cancer cells. Polym Chem. 2016;7:3530–3539.
  • Qin AJ, Zhang Y, Han N, et al. Preparation and self-assembly of amphiphilic polymer with aggregation-induced emission characteristics. Sci China Chem. 2012;55:772–778.
  • Soppimath KS, Liu LH, Seow WY, et al. Multifunctional core/shell nanoparticles self‐assembled from pH‐induced thermosensitive polymers for targeted intracellular anticancer drug delivery. Adv Funct Mater. 2007;17:355–362.
  • Lu C, Mikhail AS, Wang X, et al. Hydrogels containing core cross-linked block co-polymer micelles. J Biomater Sci Polym Edition. 2012;23:1069–1090.
  • Rubio J, Alfonso I, Bru M, et al. Gemini amphiphilic pseudopeptides: synthesis and preliminary study of their self-assembling properties. Tetrahedron Lett. 2010;51:5861–5867.
  • Jeong YI, Kim DG, Jang MK, et al. Preparation and spectroscopic characterization of methoxypoly(ethylene glycol)-grafted water-soluble chitosan. Carbohydr Res. 2008;343:282–289.
  • Tan SC, Khor E, Tan TK, et al. The degree of deacetylation of chitosan: advocating the first derivative UV-spectrophotometry method of determination. Talanta. 1998;45:713–719.
  • Crawford RM, Jovanović S, Budas GR, et al. Chronic mild hypoxia protects heart-derived h9c2 cells against acute hypoxia/reoxygenation by regulating expression of the sur2a subunit of the atp-sensitive K+ channel. J Biol Chem. 2003;278:31444–31455.
  • Chen TR. In situ detection of mycoplasma contamination in cell cultures by fluorescent Hoechst 33258 stain. Exp Cell Res. 1977;104:255–262.
  • Lerch R, Tamm C, Papageorgiou I, et al. Myocardial fatty acid oxidation during ischaemia and reperfusion. Mol Cell Biochem. 1992;116:103–109.
  • Xu SJ, Yu JJ, Zhan JJ, et al. Pharmacokinetics, tissue distribution, and metabolism study of icariin in rat. Biomed Res Int. 2017;2017:4684962–4684979.
  • Sano E, Tashiro S, Tadakuma H, et al. Type 1 IFN inhibits the growth factor deprived apoptosis of cultured human aortic endothelial cells and protects the cells from chemically induced oxidative cytotoxicity. J Cell Biochem. 2012;113:3823–3834.
  • Kaur G, Narang RK, Rath G, et al. Advances in pulmonary delivery of nanoparticles. Artif Cells Blood Substit Immobil Biotechnol. 2012;40:75–96.
  • Behera SS, Pramanik K, Nayak MK. Recent advancement in the treatment of cardiovascular diseases: conventional therapy to nanotechnology. Curr Pharma Des 2015;21:4479–4497.
  • Zhang Y, Wang F, Li MQ, et al. Self-stabilized hyaluronate nanogel for intracellular co-delivery of doxorubicin and cisplatin to osteosarcoma. Adv Sci. 2018;5:1700821–1700833.
  • Chen Y, Wu D, Zhong W, et al. Evaluation of the PEG density in the PEGylated chitosan nanoparticles as a drug carrier for curcumin and mitoxantrone. Nanomaterials. 2018;8:486–500.
  • Wu B, Feng JY, Yu LM, et al. Icariin protects cardiomyocytes against ischemia/reperfusion injury by attenuating sirt1-dependent mitochondrial oxidative damage. Br J Pharmacol. 2018;18:14457–14496.
  • Wu W, Li T, Liu J, et al. Pretreatment before ischemia induction with polymerized human placenta hemoglobin (PolyPHb) attenuates ischemia/reperfusion injury-induced myocardial apoptosis. Artif Cells Blood Substit Immobil Biotechnol. 2011;39:3–6.
  • Cui GL, Xia Q, Zhang YB, et al. Berberine differentially modulates the activities of ERK, p38 MARK, and JNK to suppress Th17 and Th1 T cell differentiation in type 1 diabetic mice. J Biol Chem. 2009;284:28420–28429.
  • Ye LY, Hu S, Xu HE, et al. The effect of tetrandrine combined with cisplatin on proliferation and apoptosis of a549/ddp cells and a549 cells. Cancer Cell Int. 2017;17:40–49.